Literature DB >> 2006152

Founder effect of a prevalent phenylketonuria mutation in the Oriental population.

T Wang1, Y Okano, R C Eisensmith, M L Harvey, W H Lo, S Z Huang, Y T Zeng, L F Yuan, J I Furuyama, T Oura.   

Abstract

A missense mutation has been identified in the human phenylalanine hydroxylase [PAH; phenylalanine 4-monooxygenase; L-phenylalanine, tetrahydrobiopterin:oxygen oxidoreductase (4-hydroxylating), EC 1.14.16.1] gene in a Chinese patient with classic phenylketonuria (PKU). A G-to-C transition at the second base of codon 413 in exon 12 of the gene results in the substitution of Pro413 for Arg413 in the mutant protein. This mutation (R413P) results in negligible enzymatic activity when expressed in heterologous mammalian cells and is compatible with a classic PKU phenotype in the patient. Population genetic studies reveal that this mutation is tightly linked to restriction fragment length polymorphism haplotype 4, which is the predominant haplotype of the PAH locus in the Oriental population. It accounts for 13.8% of northern Chinese and 27% of Japanese PKU alleles, but it is rare in southern Chinese (2.2%) and is absent in the Caucasian population. The data demonstrate unambiguously that the mutation occurred after racial divergence of Orientals and Caucasians and suggest that the allele has spread throughout the Orient by a founder effect. Previous protein polymorphism studies in eastern Asia have led to the hypothesis that "northern Mongoloids" represented a founding population in Asia. Our results are compatible with this hypothesis in that the PKU mutation might have occurred in northern Mongoloids and subsequently spread to the Chinese and Japanese populations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2006152      PMCID: PMC51186          DOI: 10.1073/pnas.88.6.2146

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  The influence of phenylalanine intake on the chemistry and behaviour of a phenyl-ketonuric child.

Authors:  H BICKEL; J GERRARD; E M HICKMANS
Journal:  Acta Paediatr       Date:  1954-01       Impact factor: 2.299

2.  Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system.

Authors:  G A JERVIS
Journal:  Proc Soc Exp Biol Med       Date:  1953-03

Review 3.  Characteristics of Mongoloid and neighboring populations based on the genetic markers of human immunoglobulins.

Authors:  H Matsumoto
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

4.  Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase.

Authors:  S C Kwok; F D Ledley; A G DiLella; K J Robson; S L Woo
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

Review 5.  The mutation and polymorphism of the human beta-globin gene and its surrounding DNA.

Authors:  S H Orkin; H H Kazazian
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

6.  Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors.

Authors:  M J Zoller; M Smith
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 7.  Phenylketonuria and other phenylalanine hydroxylation mutants in man.

Authors:  C R Scriver; C L Clow
Journal:  Annu Rev Genet       Date:  1980       Impact factor: 16.830

8.  Polymorphic DNA haplotypes at the phenylalanine hydroxylase (PAH) locus in Asian families with phenylketonuria (PKU).

Authors:  S P Daiger; L Reed; S S Huang; Y T Zeng; T Wang; W H Lo; Y Okano; Y Hase; Y Fukuda; T Oura
Journal:  Am J Hum Genet       Date:  1989-08       Impact factor: 11.025

9.  Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria.

Authors:  R Chakraborty; A S Lidsky; S P Daiger; F Güttler; S Sullivan; A G Dilella; S L Woo
Journal:  Hum Genet       Date:  1987-05       Impact factor: 4.132

10.  Gm and Km allotypes in 74 Chinese populations: a hypothesis of the origin of the Chinese nation.

Authors:  T M Zhao; T D Lee
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

View more
  15 in total

1.  Three prevalent mutations in a patient with phenylalanine hydroxylase deficiency: implications for diagnosis and genetic counselling.

Authors:  P Guldberg; H L Levy; K F Henriksen; F Guttler
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

Review 2.  A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria.

Authors:  H Erlandsen; R C Stevens
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

3.  Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: absence of the common Jewish 84GG and 1226G mutations.

Authors:  H Ida; K Iwasawa; H Kawame; O M Rennert; K Maekawa; Y Eto
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

4.  Molecular and population genetics of phenylketonuria in Orientals: correlation between phenotype and genotype.

Authors:  Y Okano; Y Hase; D H Lee; G Takada; Y Shigematsu; T Oura; G Isshiki
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  Spatial and temporal distribution of the neutral polymorphisms in the last ZFX intron: analysis of the haplotype structure and genealogy.

Authors:  J Jaruzelska; E Zietkiewicz; M Batzer; D E Cole; J P Moisan; R Scozzari; S Tavaré; D Labuda
Journal:  Genetics       Date:  1999-07       Impact factor: 4.562

Review 6.  Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants.

Authors:  J Flint; R M Harding; J B Clegg; A J Boyce
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

7.  Evidence of a founder effect for the 235delC mutation of GJB2 (connexin 26) in east Asians.

Authors:  Denise Yan; Hong-Joon Park; Xiao Mei Ouyang; Arti Pandya; Katsumi Doi; Raadnabazar Erdenetungalag; Li Lin Du; Naoki Matsushiro; Walter E Nance; Andrew J Griffith; Xue Zhong Liu
Journal:  Hum Genet       Date:  2003-09-18       Impact factor: 4.132

8.  Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.

Authors:  D Phaneuf; M Lambert; R Laframboise; G Mitchell; F Lettre; R M Tanguay
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  Recurrence of the R408W mutation in the phenylalanine hydroxylase locus in Europeans.

Authors:  R C Eisensmith; A A Goltsov; C O'Neill; L A Tyfield; E I Schwartz; A I Kuzmin; S S Baranovskaya; G L Tsukerman; E Treacy; C R Scriver
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  Evidence in Latin America of recurrence of V388M, a phenylketonuria mutation with high in vitro residual activity.

Authors:  L R Desviat; B Pérez; M De Lucca; V Cornejo; B Schmidt; M Ugarte
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.